-
Je něco špatně v tomto záznamu ?
Altered Indices of Fatty Acid Elongases ELOVL6, ELOVL5, and ELOVL2 Activities in Patients with Impaired Fasting Glycemia
J. Macášek, M. Zeman, A. Žák, B. Staňková, M. Vecka
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
33983851
DOI
10.1089/met.2021.0012
Knihovny.cz E-zdroje
- MeSH
- elongasy mastných kyselin * krev MeSH
- krevní glukóza * analýza MeSH
- lidé MeSH
- metabolický syndrom epidemiologie MeSH
- omezení příjmu potravy * krev MeSH
- studie případů a kontrol MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Background: Dysregulation of fatty acids (FA) seems to participate in the pathogenesis of disorders such as metabolic syndrome (MetS), cardiovascular diseases, or some cancers. Activities of enzymes FA desaturases and elongases [elongation of very long-chain fatty acid (ELOVL)] significantly influence FA profile in different body compartments. Although the impact of activities of desaturases on cardiometabolic diseases was broadly studied, relatively little attention was devoted to the role of elongases. Methods: Case-control study was carried out in 36 patients (18 men/18 women) with impaired fasting glycemia (IFG) without MetS and 36 age and gender-matched healthy controls. FA profiles in plasma phospholipids (PL) were assessed using gas chromatograph-flame ionization detector and indices of desaturase and elongase activities were calculated. Results: In the IFG group, we observed decreased estimated activities of ELOVL2 and ELOVL5, whereas higher estimated activities of elongase ELOVL6 were noted. IFG group was also characterized by altered composition of plasma PL FA, above all by lower percentage of cis-vaccenic acid (cVA; 18:1n-7) and of total polyunsaturated FA n-6, especially linoleic acid, and by higher proportion of stearic acid and gamma-linolenic acid. Concurrently, elevated estimated activities of desaturases delta-9-desaturase (D9D), D6D were found. Conclusions: Lower estimated activities of ELOVL2 and ELOVL5 with lowered proportion of PL cVA could be associated with disturbances of glucose homeostasis development and their corresponding indices could serve as biomarkers of such risk.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012261
- 003
- CZ-PrNML
- 005
- 20220506130358.0
- 007
- ta
- 008
- 220425s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/met.2021.0012 $2 doi
- 035 __
- $a (PubMed)33983851
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Macášek, Jaroslav $u 4th Department of Medicine, First Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000280098970 $7 xx0086045
- 245 10
- $a Altered Indices of Fatty Acid Elongases ELOVL6, ELOVL5, and ELOVL2 Activities in Patients with Impaired Fasting Glycemia / $c J. Macášek, M. Zeman, A. Žák, B. Staňková, M. Vecka
- 520 9_
- $a Background: Dysregulation of fatty acids (FA) seems to participate in the pathogenesis of disorders such as metabolic syndrome (MetS), cardiovascular diseases, or some cancers. Activities of enzymes FA desaturases and elongases [elongation of very long-chain fatty acid (ELOVL)] significantly influence FA profile in different body compartments. Although the impact of activities of desaturases on cardiometabolic diseases was broadly studied, relatively little attention was devoted to the role of elongases. Methods: Case-control study was carried out in 36 patients (18 men/18 women) with impaired fasting glycemia (IFG) without MetS and 36 age and gender-matched healthy controls. FA profiles in plasma phospholipids (PL) were assessed using gas chromatograph-flame ionization detector and indices of desaturase and elongase activities were calculated. Results: In the IFG group, we observed decreased estimated activities of ELOVL2 and ELOVL5, whereas higher estimated activities of elongase ELOVL6 were noted. IFG group was also characterized by altered composition of plasma PL FA, above all by lower percentage of cis-vaccenic acid (cVA; 18:1n-7) and of total polyunsaturated FA n-6, especially linoleic acid, and by higher proportion of stearic acid and gamma-linolenic acid. Concurrently, elevated estimated activities of desaturases delta-9-desaturase (D9D), D6D were found. Conclusions: Lower estimated activities of ELOVL2 and ELOVL5 with lowered proportion of PL cVA could be associated with disturbances of glucose homeostasis development and their corresponding indices could serve as biomarkers of such risk.
- 650 12
- $a krevní glukóza $x analýza $7 D001786
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 12
- $a omezení příjmu potravy $x krev $7 D005215
- 650 12
- $a elongasy mastných kyselin $x krev $7 D000081031
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a metabolický syndrom $x epidemiologie $7 D024821
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zeman, Miroslav $u 4th Department of Medicine, First Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/000000015338603X $7 skuk0006053
- 700 1_
- $a Žák, Aleš $u 4th Department of Medicine, First Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Staňková, Barbora $u 4th Department of Medicine, First Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Vecka, Marek $u 4th Department of Medicine, First Medical Faculty, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000232691817 $7 xx0076497
- 773 0_
- $w MED00007472 $t Metabolic syndrome and related disorders $x 1557-8518 $g Roč. 19, č. 7 (2021), s. 386-392
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33983851 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130350 $b ABA008
- 999 __
- $a ok $b bmc $g 1789728 $s 1163462
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 19 $c 7 $d 386-392 $e 20210513 $i 1557-8518 $m Metabolic syndrome and related disorders $n Metab Syndr Relat Disord $x MED00007472
- LZP __
- $a Pubmed-20220425